GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Optomed PLC (FRA:36U0) » Definitions » Additional Paid-In Capital

Optomed (FRA:36U0) Additional Paid-In Capital : €0.50 Mil(As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Optomed Additional Paid-In Capital?


Optomed's quarterly additional paid-in capital stayed the same from Sep. 2024 (€0.50 Mil) to Dec. 2024 (€0.50 Mil) and stayed the same from Dec. 2024 (€0.50 Mil) to Mar. 2025 (€0.50 Mil).

Optomed's annual additional paid-in capital stayed the same from Dec. 2022 (€0.50 Mil) to Dec. 2023 (€0.50 Mil) and stayed the same from Dec. 2023 (€0.50 Mil) to Dec. 2024 (€0.50 Mil).


Optomed Additional Paid-In Capital Historical Data

The historical data trend for Optomed's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optomed Additional Paid-In Capital Chart

Optomed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.50 0.50 0.50 0.50

Optomed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.50 0.50 0.50 0.50

Optomed Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Optomed Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Optomed's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Optomed Business Description

Traded in Other Exchanges
Address
Yrttipellontie 1, Oulu, FIN, 90230
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company operates in two business segments which are Devices and Software. Devices segment develops, commercializes, and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma, and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.

Optomed Headlines

No Headlines